Grant: Team Grant: Bringing Biology to Cancer Prevention - General Pool
Université Laval
$0.00
Harnessing the gut microbiome-prostate cancer crosstalk to discover predictive biomarkers of risk and potential preventive strategies
EF 2025-26
Résumé
The gut microbiome, which is made up of billions of bacteria in our digestive system, is becoming more recognized as a key part of our overall health. These bacteria help manage many chronic diseases and support our immune system. The microbes in our gut have different functions. One important job of these bacteria is producing compounds that are essential for our health. The gut microbiome can be affected by diet, exercise, and medications.
Our research has found a two-way relationship between the gut microbiome and prostate cancer. We found that aggressiveness of prostate cancer can affect the types of bacteria in the gut, and in turn, those bacteria may help the cancer grow. Our early results show that men with different stages of prostate cancer have different types of gut bacteria. Even more interestingly, men who are at risk of prostate cancer - but don't yet have a diagnosis - show bacterial differences depending on whether they eventually develop cancer. This suggests that gut bacteria could play a role in both the development and severity of prostate cancer.
We also know that lifestyle factors like diet can affect both gut bacteria and how aggressive prostate cancer is. In other types of cancer, gut microbes have been linked to how well patients respond to treatment, but this hasn't yet been studied in prostate cancer.
In this study, we aim to better understand the connection between gut bacteria, lifestyle, and prostate cancer development and aggressiveness. First, we will test how gut bacteria from men with and without prostate cancer affect cancer development in laboratory models. We will also recruit 450 men at risk of prostate cancer to study their gut bacteria, diet, lifestyle and health over time. Our goal is to find gut bacterial signatures that could help predict who will develop prostate cancer and how severe it might become - opening the door to better prevention and more personalized care.
Programme
Team Grant: Bringing Biology to Cancer Prevention - General Pool
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
560765
Name
Fradet Vincent
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
The Terry Fox Research Institute (Vancouver, BC); Canadian Cancer Society - National Office (Toronto)
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Team Grant: Bringing Biology to Cancer Prevention
Projecttitle
Harnessing the gut microbiome-prostate cancer crosstalk to discover predictive biomarkers of risk and potential preventive strategies
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$0
Cihrequipment2
$0
Programname2
Team Grant: Bringing Biology to Cancer Prevention - General Pool
Keyworddelim
Avatar Mouse Models; Biomarkers; Genetically Engineered Mouse Models Of Prostate Cancer; Gut Microbiota; Lifestyle Habits; Metagenomics; Observational Study; Prebiotics; Probiotics; Prostate Cancer Risk
Abstract
The gut microbiome, which is made up of billions of bacteria in our digestive system, is becoming more recognized as a key part of our overall health. These bacteria help manage many chronic diseases and support our immune system. The microbes in our gut have different functions. One important job of these bacteria is producing compounds that are essential for our health. The gut microbiome can be affected by diet, exercise, and medications.
Our research has found a two-way relationship between the gut microbiome and prostate cancer. We found that aggressiveness of prostate cancer can affect the types of bacteria in the gut, and in turn, those bacteria may help the cancer grow. Our early results show that men with different stages of prostate cancer have different types of gut bacteria. Even more interestingly, men who are at risk of prostate cancer - but don't yet have a diagnosis - show bacterial differences depending on whether they eventually develop cancer. This suggests that gut bacteria could play a role in both the development and severity of prostate cancer.
We also know that lifestyle factors like diet can affect both gut bacteria and how aggressive prostate cancer is. In other types of cancer, gut microbes have been linked to how well patients respond to treatment, but this hasn't yet been studied in prostate cancer.
In this study, we aim to better understand the connection between gut bacteria, lifestyle, and prostate cancer development and aggressiveness. First, we will test how gut bacteria from men with and without prostate cancer affect cancer development in laboratory models. We will also recruit 450 men at risk of prostate cancer to study their gut bacteria, diet, lifestyle and health over time. Our goal is to find gut bacterial signatures that could help predict who will develop prostate cancer and how severe it might become - opening the door to better prevention and more personalized care.
Competitiondate
202506
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Fradet, Vincent; Isabel, Sandra; Labbé, David
Approvedterm
5 ans 0 mois